Peter Sabaka

728 total citations
40 papers, 367 citations indexed

About

Peter Sabaka is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, Peter Sabaka has authored 40 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Epidemiology. Recurrent topics in Peter Sabaka's work include Lipoproteins and Cardiovascular Health (5 papers), Heart Rate Variability and Autonomic Control (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Peter Sabaka is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Heart Rate Variability and Autonomic Control (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). Peter Sabaka collaborates with scholars based in Slovakia, Czechia and Spain. Peter Sabaka's co-authors include Andrej Dukát, Peter Kružliak, Ľudovít Gašpar, Martin Čaprnda, Július Hodosy, Luı́s Rodrigo, Stanislav Oravec, Anthony Zulli, Fedor Šimko and Daniel Petrovič and has published in prestigious journals such as International Journal of Molecular Sciences, Oxidative Medicine and Cellular Longevity and Applied Sciences.

In The Last Decade

Peter Sabaka

36 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Sabaka Slovakia 11 109 90 82 76 53 40 367
Emmanouil Korakas Greece 12 98 0.9× 78 0.9× 149 1.8× 73 1.0× 91 1.7× 47 562
Konstantinos Balampanis Greece 7 97 0.9× 58 0.6× 105 1.3× 48 0.6× 129 2.4× 18 367
Victorița Șorodoc Romania 13 88 0.8× 61 0.7× 48 0.6× 27 0.4× 24 0.5× 63 402
Tisha Suboc United States 7 98 0.9× 39 0.4× 43 0.5× 90 1.2× 43 0.8× 29 327
Zihui Tang China 14 159 1.5× 79 0.9× 25 0.3× 72 0.9× 58 1.1× 64 579
Gabriele Brosolo Italy 13 147 1.3× 65 0.7× 20 0.2× 31 0.4× 104 2.0× 32 335
Takashi Kajiya Japan 10 142 1.3× 136 1.5× 36 0.4× 28 0.4× 47 0.9× 33 389
María D. López-Carmona Spain 11 65 0.6× 53 0.6× 54 0.7× 64 0.8× 152 2.9× 29 378
Wen-Ting Yeh Taiwan 9 204 1.9× 41 0.5× 34 0.4× 55 0.7× 80 1.5× 9 464
М. А. Исаков Russia 10 97 0.9× 84 0.9× 30 0.4× 48 0.6× 305 5.8× 38 532

Countries citing papers authored by Peter Sabaka

Since Specialization
Citations

This map shows the geographic impact of Peter Sabaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Sabaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Sabaka more than expected).

Fields of papers citing papers by Peter Sabaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Sabaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Sabaka. The network helps show where Peter Sabaka may publish in the future.

Co-authorship network of co-authors of Peter Sabaka

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Sabaka. A scholar is included among the top collaborators of Peter Sabaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Sabaka. Peter Sabaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aziriova, Silvia, Peter Stanko, Kristina Repova, et al.. (2025). Effect of Sacubitril/Valsartan, Ivabradine, and Captopril on Anxiety-like Behavior in Spontaneously Hypertensive Rats. International Journal of Molecular Sciences. 26(22). 10905–10905. 1 indexed citations
2.
Sabaka, Peter, et al.. (2025). Autoimmune encephalitis associated with anti-SOX1 autoantibodies in COVID-19: A case report. IDCases. 40. e02220–e02220.
3.
Sabaka, Peter, et al.. (2024). Analysis of transcriptomics data from COVID-19 patients: a pilot research. Folia Microbiologica. 69(1). 155–164. 4 indexed citations
4.
Hunáková, Ľuba, et al.. (2023). Linear and non‑linear indices of vagal nerve in relation to sex and inflammation in patients with Covid‑19. Biomedical Reports. 19(5). 80–80. 1 indexed citations
5.
Hodosy, Július, et al.. (2023). Antimicrobial Therapy as a Risk Factor of Multidrug‐Resistant Acinetobacter Infection in COVID‐19 Patients Admitted to the Intensive Care Unit. Canadian Journal of Infectious Diseases and Medical Microbiology. 2023(1). 4951273–4951273. 2 indexed citations
6.
Sabaka, Peter, et al.. (2023). Ct Value from RT-qPCR Can Predict SARS-CoV-2 Virus Assembly and Lineage Assignment Success. Applied Sciences. 13(18). 10431–10431. 2 indexed citations
7.
Stevens, Roy H., et al.. (2023). Successful use of a phage endolysin for treatment of chronic pelvic pain syndrome/chronic bacterial prostatitis. Frontiers in Medicine. 10. 1238147–1238147. 7 indexed citations
10.
11.
Sabaka, Peter, et al.. (2017). The effects of body weight loss and gain on arterial hypertension control: an observational prospective study. European journal of medical research. 22(1). 43–43. 21 indexed citations
12.
Sabaka, Peter, Martin Čaprnda, Daniel Petrovič, et al.. (2017). Atherogenic index of plasma is positively associated with the risk of all-cause death in elderly women. Wiener klinische Wochenschrift. 129(21-22). 793–798. 34 indexed citations
13.
Gašpar, Ľudovít, Peter Kružliak, Luı́s Rodrigo, et al.. (2016). Contribution of prostaglandin E1 treatment in patients with critical limb ischemia. 9(2). 2 indexed citations
14.
Kružliak, Peter, Luı́s Rodrigo, J Gonsorčík, et al.. (2016). Effect of Low Dose Atorvastatin Therapy on Baroreflex Sensitivity in Hypertensives. High Blood Pressure & Cardiovascular Prevention. 23(2). 133–140. 5 indexed citations
15.
Sabaka, Peter, et al.. (2015). Effect of hyperbaric oxygen on lipoprotein subfractions in diabetic patients.. PubMed. 42(5). 399–407. 4 indexed citations
16.
Kružliak, Peter, Ľudovít Gašpar, Miroslav Souček, et al.. (2015). Prognostic significance of dipping in older hypertensive patients. Blood Pressure. 24(2). 103–110. 13 indexed citations
17.
Kružliak, Peter, Rachele Ciccocioppo, Stanislav Oravec, et al.. (2015). The effects of atorvastatin treatment on the mean platelet volume and red cell distribution width in patients with dyslipoproteinemia and comparison with plasma atherogenicity indicators—A pilot study. Clinical Biochemistry. 48(9). 557–561. 26 indexed citations
18.
Sabaka, Peter, Peter Kružliak, Giovanni Cammarota, et al.. (2015). Effect of short term aerobic exercise on fasting and postprandial lipoprotein subfractions in healthy sedentary men. Lipids in Health and Disease. 14(1). 151–151. 10 indexed citations
19.
Gašpar, Ľudovít, Peter Kružliak, B Krahulec, et al.. (2015). Orthostatic hypotension in diabetic patients—10-year follow-up study. Journal of Diabetes and its Complications. 30(1). 67–71. 31 indexed citations
20.
Sabaka, Peter, Peter Kružliak, Ľudovít Gašpar, et al.. (2013). Postprandial changes of lipoprotein profile: effect of abdominal obesity. Lipids in Health and Disease. 12(1). 179–179. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026